Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious diseases, University Hospital Regensburg, Regensburg, Bavaria, Germany.
Department of Pathology, University Hospital Regensburg, Regensburg, Bavaria, Germany.
Gut. 2022 Mar;71(3):580-592. doi: 10.1136/gutjnl-2020-321663. Epub 2021 Mar 11.
Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis with a 1-year mortality of 66%. Bacterial translocation (BT) from the intestine to the mesenteric lymph nodes is crucial for the pathogenesis of SBP.
Since BT presupposes a leaky intestinal epithelium, the integrity of mucus and epithelial cell junctions (E-cadherin and occludin) was examined in colonic biopsies from patients with liver cirrhosis and controls. SBP-inducing () and () were isolated from ascites of patients with liver cirrhosis and co-cultured with Caco-2 cells to characterise bacteria-to-cell effects.
SBP-derived and led to a marked reduction of cell-to-cell junctions in a dose-dependent and time-dependent manner. This effect was enhanced by a direct interaction of live bacteria with epithelial cells. Degradation of occludin is mediated via increased ubiquitination by the proteasome. Remarkably, a novel bacterial protease activity is of pivotal importance for the cleavage of E-cadherin.
Patients with liver cirrhosis show a reduced thickness of colonic mucus, which allows bacteria-to-epithelial cell contact. Intestinal bacteria induce degradation of occludin by exploiting the proteasome of epithelial cells. We identified a novel bacterial protease activity of patient-derived SBP-inducing bacteria, which is responsible for the cleavage of E-cadherin structures. Inhibition of this protease activity leads to stabilisation of cell junctions. Thus, targeting these mechanisms by blocking the ubiquitin-proteasome system and/or the bacterial protease activity might interfere with BT and constitute a novel innovative therapeutic strategy to prevent SBP in patients with liver cirrhosis.
自发性细菌性腹膜炎(SBP)是肝硬化的一种危及生命的并发症,其 1 年死亡率为 66%。细菌从肠道转移到肠系膜淋巴结对于 SBP 的发病机制至关重要。
由于 BT 假定肠上皮通透性增加,因此检查了肝硬化患者和对照组的结肠活检中粘液和上皮细胞连接(E-钙粘蛋白和闭合蛋白)的完整性。从肝硬化患者的腹水中分离出 SBP 诱导的()和(),并用其与 Caco-2 细胞共培养以表征细菌对细胞的作用。
SBP 衍生的()和()以剂量和时间依赖的方式导致细胞间连接明显减少。活细菌与上皮细胞的直接相互作用增强了这种作用。封闭蛋白的降解是通过蛋白酶体介导的泛素化增加介导的。值得注意的是,一种新型细菌蛋白酶活性对于 E-钙粘蛋白的切割至关重要。
肝硬化患者的结肠粘液厚度降低,这使得细菌能够与上皮细胞接触。肠道细菌通过利用上皮细胞的蛋白酶体诱导封闭蛋白的降解。我们鉴定了一种新型细菌蛋白酶活性,该活性负责切割 E-钙粘蛋白结构。抑制这种蛋白酶活性可稳定细胞连接。因此,通过阻断泛素-蛋白酶体系统和/或细菌蛋白酶活性来靶向这些机制可能会干扰 BT,并构成预防肝硬化患者 SBP 的一种新的创新治疗策略。